ArticleImmuno-oncology technology2025

Ligand-receptor interactions of V-domain Ig-containing suppressor of T cell activation and programmed death-1 suppress the anticancer activities of T cells.

M Abooali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.